Introduction
Chronic myeloid leukemia (CML) is a clonal disease resulting from the proliferation of a multipotent hematopoietic cell which keeps its ability to differentiate. 1 The malignant clone is characterized by t(9;22) chromosomal translocation, also termed Philadelphia or Ph chromosome. 2, 3 At the molecular level, the Ph translocation juxtaposes the protooncogene c-ABL on chromosome 9 to the BCR gene on chromosome 22 . The BCR/ABL gene product is a 210 kDa protein with increased tyrosine kinase activity. 4 Treatment of CML includes monochemotherapy with hydroxyurea or busulfan, interferon alpha (IFN␣), and autologous or allogeneic bone marrow transplantation. 5, 6 Only this last treatment achieves long-term cytogenetic and molecular remissions. However, IFN␣ and autologous transplantation can induce cytogenetic remissions, which are probably associated with longer survival. 6, 7 Autologous transplantation can be performed with bone marrow (BM) cells or peripheral blood (PB) stem cells harvested by cytapheresis at the time of diagnosis or after intensive cytoreductive therapy. 8 Normal hematopoietic cells persist in the marrow or in the blood of CML patients at diagnosis or in early phase of the disease, whereas a large majority of the harvested cells usually belong to the malignant clone and are able to contribute to relapse after transplantation. 9 Since the demonstration of the persistence in CML patients of Ph-negative progenitor cells, 10 several strategies have been proposed to eliminate the malignant cells from the graft, such as in vitro incubation with chemotherapeutic agents, 11, 12 interferon gamma, 13 or antisense oligodeoxynucleotides, 14 ex vivo marrow culture 15 or in vivo purging (harvest after intensive chemotherapy). [16] [17] [18] [19] [20] Although this contributes in decreasing the proportion of Ph cells in the graft, a complete purging is not achieved by these methods. Immunological sorting of cells exhibiting the CD34
+ DR − phenotype may select normal very primitive stem cells, at least when performed in early stages of the disease. [21] [22] [23] However, the immunological phenotype of Ph primitive 'stem cells' is still a subject of controversy, [24] [25] [26] and complex immunological sorting is not easily feasible in view of a large clinical application.
The evidence that normal hematopoiesis persisted in patients with CML was first provided by long-term culture (LTC) studies. 10 In this system, normal progenitor cells may have a proliferative or survival advantage over their Ph equivalents. Long-term cultures were therefore proposed for ex vivo selection of normal marrow cells. This method is complex, time-consuming and yields a high risk of contamination. Moreover, an efficient purging is not achieved in a number of cases. 15 Berardi et al 27 described a culture system that allowed the selection of very primitive human hematopoietic stem cells: marrow CD34-positive cells or mononuclear cells (MNC) are cultured for 1 week in the presence of interleukin-3 (IL-3), stem cell factor (SCF) and 5-fluorouracil (5-FU). Stem cells lacking the IL-3 receptor remain quiescent and therefore escape the effect of 5-FU, which is only active on cells pushed into cycle by the combination of IL-3 and SCF. The cells selected by this method exhibit multilineage potential as well as self-renewal properties in LTC. We show here that it is possible to use this culture technique to easily select BCR/ABLnegative hematopoietic stem cells from blood or marrow of CML patients at diagnosis or during IFN␣ therapy.
Materials and methods

Patients and cells
Cells were obtained by bone marrow (BM) aspiration from 10 patients with CML at diagnosis (case numbers 1 to 10). In addition, peripheral blood (PB) also taken at diagnosis by venipuncture was studied in four of these patients. Marrow cells were collected from 7 patients (case numbers 11 to 17) who had been treated by IFN␣ for 3 to 15 months (all patients were in hematological remission, but marrow karyotype showed 26 to 100% Ph-positive mitoses). Detailed patient characteristics are presented in Table 1 .
Controls were performed with normal bone marrow from five healthy donors for allogeneic transplantation.
Bone marrow and peripheral blood cell exposure to 5-FU, IL-3 and SCF
The low-density, adherence-depleted mononuclear cells (MNC) from BM and PB were plated on to 24-well flat-bottom plates (Nunc, Naperville, IL, USA) and incubated for 7 days at a concentration of 5 × 10 5 cells/ml in Iscove's modified Dulbecco's medium (Gibco BRL, Paisley, UK) containing 10% fetal calf serum (Eurobio Laboratories, Les Ullis, France), 5-FU (0.6 mg/ml) (Roche, Basel, Switzerland), and supplemented with IL-3 (100 ng/ml, Peprotech EC, Rocky Hill, NJ, USA) and SCF (100 ng/ml) (kindly provided by Amgen, Thousand Oaks, CA, USA). On day 7, cells were washed and viability was evaluated by trypan blue exclusion test.
In some experiments, CD34-positive cells were used instead of MNC. MNC were labeled with a magnetic particle coupled CD34 antibody (Qbend 10) and CD34
+ cells isolated using miniMACS columns as recommended by the manufacturer (Miltenyi Biotec, Camberley, UK). 28 Purity was always more than 90% as determined by CD34 staining.
When a large number of 5-FU-selected cells were needed (ie SCID mouse experiments), CD34 + cells were seeded into 75 cm 2 ml Falcon Tissue Culture Flasks (Becton Dickinson Labware, Franklin Lakes, NJ, USA) at the same cell and growth factor concentrations as above.
Long-term cultures
To establish the stromal layer, MNC from normal BM were placed into 6-well Petri dishes plates (Falcon, Becton Dickinson) in long-term culture medium (Myelocult, StemCell Technologies, Vancouver, BC, Canada) supplemented with 10 −6 m/l hydrocortisone (Sigma, St Louis, MO, USA), penicillin (100 U/ml) streptomycin (100 U/ml) (Gibco BRL) and cultured for 7 days at 37°C in a fully humidified atmosphere with 5% CO 2 . The culture was then transferred to 33°C and grown until confluence, at which time cells were trypsinized, washed, irradiated (15 Gy) and subcultured in 24-well flat-bottomed plates (Nunc, Oslo, Norway) at a density of 3 × 10 4 /cm 2 . After 1 day, 1000 5-FU-selected cells (or control cells) were seeded into these wells. In some experiments limiting dilution assays were performed. One, 5, 10 and 100 cells were seeded per well, using a FACStar flow cytometer equipped with a Cell Deposition unit (Becton Dickinson, Mountain View, CA, USA). Cultures were then fed weekly by replacement of half the Myelocult medium. Every 7 days and at the end of the 5-week culture, wells were evaluated as positive or negative for the presence of cobblestone areas, defined as clusters of small, tightly packed cells that were non-refractory when viewed under a phase contrast microscope. 29 When cobblestone areas of more than 15 cells or when three separate foci of more than five cells were observed, wells were scored as positive. After 5 weeks adherent cells were trypsinized, washed, and plated together with non-adherent cells in methylcellulose for progenitor assay.
Progenitor assays
Cells were plated in 0.8% methylcellulose, supplemented with 30% fetal calf serum, bovine serum albumin. 10 −4 m 2-mercaptoethanol, transferrin, 2 mm l-glutamine, IL-3, IL-6, SCF, erythropoietin, G-CSF, GM-CSF and IL-11 (STEM␣.1D, STEM␣, Villeneuve Saint Georges, France) and scored at 14 and 21 days for colony formation. Each experiment was performed in triplicate.
Immunophenotype
After 7 days of culture with 5-FU, IL-3 and SCF, cells were washed and incubated at 4°C with fluorescein isothiocyanateconjugated CD34, CD38, CD117, CD33, CD13, CD19, or HLA-DR antibodies (Coulter Immunology, Hialeah, FL, USA) for 30 min, washed three times with cold phosphate-buffered saline (PBS). After addition of propidium iodide, cells were examined by fluorescence microscopy. Negative controls were performed using appropriate mouse isotypic antibodies (Coulter Immunology).
Fluorescence in situ hybridization (FISH)
FISH studies were performed on cells recovered at the end of a 5-week LTC (pooled adherent and non-adherent cells), or on individual colonies grown in methylcellulose plucked with a fine Pasteur pipette. Cells were put on to a glass slide, left to dry and fixed in methanol/acetic acid (3:1). Slides were stored at −30°C. After thawing, the slides were incubated with 0.1 mg/ml RNAse A (Boehringer Mannheim, Mannheim, Germany) in two times standard saline citrate (2 × SSC) at 37°C for 1 h, followed by incubation with pepsin (Sigma) (20 l of 10% pepsin solution in 40 ml of 0.01 n HCL for 13 min at 37°C). Postfixation was performed with 1% paraformaldehyde in PBS containing 0.18 g MgCl 2 . The slides were then dehydrated in ethanol and left to dry. DNA was denatured at 73°C for 5 min in 70% formamide in 2 × SSC. The slides were dehydrated in ethanol. LSI BCR/ABL dual-color translocation probe (a mixture of a bcr probe directly labeled with Spectrum Green fluorophore, which covers approximately 300 kb immediately 5Ј of the major breakpoint region and a abl probe directly labeled with Spectrum Orange fluorophore which covers 200 kb and lies 3Ј of exon IV) (Vysis Inc, IL, USA) was mixed with the hybridization buffer and then denatured at 73°C for 5 min. Ten microliters of probe/hybridization solution were layered on to the slides. Coverslips were sealed with rubber cement. After 16 h of hybridization at 37°C the rubber cement was removed and the cells washed in 0.4 × SSC/0.3% NP40 for 2 min at 73°C. The slides were washed in 2 × SSC/0.1% NP40 at room temperature for at least 5 and air dried in darkness. Ten microliters of DAPI II counterstain (Vysis, Downers Grove, IL, USA) were added to the slide and a coverslip was placed.
Samples were scored with a fluorescence microscope (Leitz, Wetzlar, Germany) using a double bandpass filter. All analyses were performed using cells with good nuclear morphology and complete non-overlapping nuclei. A cell was scored Phpositive if it contained one distinct red signal, one distinct green signal and one distinct yellow signal, representing the coincidence of a red and a green signal and also when a nucleus contained two red and two green signals with one red and one green in close juxtaposition. A colony was scored when at least 10 nuclei could be evaluated, and when 60% of the cells at least exhibited the same signal. An average of 50 cells per colony were examined. Scoring of each sample was performed by two independent observers.
PCR studies RNA extraction:
Cells from pooled colonies, or from 5-week LTC were transferred into vials containing 100 l RNAzol lyse solution. Ten microliters of chloroform were added to the homogenate, which was vortexed, kept on ice for 5 min, and then centrifuged at 4°C for 15 min. RNA from the upper aqueous phase was removed with a pipette and transferred into 0.6 ml vials (Perkin-Elmer Cetus, Branchburg, NJ, USA). An equal volume of isopropanol was added, and the solution was left at 4°C for 15 min to allow precipitation. The solution was then centrifuged at 12 000 g at 4°C for 15 min. The supernatant was removed, and RNA pellets were washed with 200 l of 75% ethanol and then spun down (at 4°C for 10 min). RNA pellets were then dried on speed vacuum for 10 min and dissolved in 40 l of sterile double water. Total RNA was divided into two parts, one for BCR/ABL mRNA by RT-PCR and the other to establish RNA integrity by testing for normal ABL sequence transcription. RNA from K562 cells, a CML erythroid blast crisis cell line and from patients with Phpositive CML were used as positive controls for mRNA. HL-60 (a Ph-negative myelocytic leukemic cell line) and normal human blood RNA were used as negative controls.
cDNA preparation:
Six microliters of reaction mixture were prepared as follows: 4 l of 5 × reverse transcriptase buffer; 0.5 l of RNAsin (40 UI/l) (Promega Corporation, Madison, WI, USA); 2 l of 10 mm dNTPs (mix of dATP, dCTP, dGTP and dTTP); 7.5 l of H 2 O; 1 l of M-MLV reverse transcriptase (200 U/l) (Gibco BRL); and 1 l of 3Ј primer (10 pmol/l) or 1 l of hexanucleotides (100 m) (Pharmacia Biotech, Uppsala, Sweden). The 16 l of reaction mixture were added to 4 l of total RNA (1/10 of colonies total RNA). The RNA reaction mixture was then incubated at 42°C for 60 min.
Amplification of CDNA:
The RT-PCR reaction mixture was prepared was follows: 8 l of 10 × reaction buffer (Gene Amp Kit, Perkin-Elmer Cetus), 4 l of 3Ј primer (10 pmol/l), 5 l of 5Ј primer (10 pmol/l), 0.5 l of Taq polymerase enzyme (5 U/l) (Perkin-Elmer Cetus), 6 l of dNTPs and 56.5 l of H 2 O. After centrifugation, the 80 l of RT-PCR reaction mixture was added to the 20 l solution of cDNA obtained above, mixed well, centrifuged, and overlaid with 100 l of mineral oil (Perkin-Elmer Cetus) to prevent evaporation. The RT-PCR amplification was performed for 35 cycles.
Primers:
The primers were 5Ј-GAGCGTGCAGAGTGGA GGGAGAACATCCGG-3Ј (5Ј primer homologous to sequences in BCR) and 5Ј-CCATTTTTGGTTTGGGC TTCA-CACCATTCC −3Ј (3Ј primer homologous to sequences in ABL). The actin primers were 5Ј-GAAGCATTTGCGGTGGAC-CAT-3Ј and 5Ј-TCCTGTGGCA TCCACCAAACT-3Ј. A second round of PCR was performed with 10 pmol of internal nested primers ABL: 5Ј-TGTGATTATAGCCTAAGACCCGGAGCTT TTC-3Ј and BCR: 5Ј-GAAGAAGTGTTTCAGAA GCTTCTCC-3Ј, with 100 l of reaction mixture containing 5 l of firstround products as the template for an additional 35 cycles. PCR products were separated electrophoretically through 2% agarose.
To avoid false-negative results, all cells were simultaneously coamplified for the normal ABL transcript or for ␤ actin to ensure the presence of intact cDNA and a successful amplification procedure.
NOD/SCID mouse engraftment
Sublethally irradiated (0.4 Gy) 6-week-old mice were transplanted intravenously with 5-FU-selected cells, or with 10 6
CD34
+ cells as positive controls. Mice were sacrificed at week 10 post transplant. The presence of human cells in blood was evaluated by flow cytometry using CD45. CD13 and CD19 antibodies. RT-PCR studies were performed simultaneously on blood cells to assess normal ABL and BCR/ABL gene products. The frequency of CAFC in the marrow was evaluated by plating 100 MNC on human stromal layer as described above.
Results
Cell selection by 5-FU, IL-3 and SCF
For each patient, the total number of MNC collected was between 1.6 and 6. + cells were used, the recovery of viable cell was between 533 and 1033 cells for 10 6 cells placed in culture. Detailed results are given in Figure 1 .
The results obtained with normal marrow MNC were simi- 
Cell immune phenotype
In all cases (patients and controls), viable cells recovered after culture were homogeneously CD34 and CD117-positive (97-100% positive cells), and CD38, CD33, CD13, CD19 and DRnegative (0-1% positive cells).
Cobblestone area forming cells (CAFC)
Limiting dilution analyses were performed to assess the frequency of CAFC in 5-FU selected populations from five CML samples at diagnosis and five normal marrow. The frequency of CAFC-positive cultures for one cell seeded was 0.46 for normal marrow, 0.5 for CML marrow and 0.33 for CML blood, which is not statistically significant. Detailed results are given in Table 2 .
Secondary colonies
The efficiency of LTCs was assessed by enumeration of secondary colonies obtained in clonogeneic assay after 5 weeks of culture (Figure 2 ). The number of 21-day colonies (all types) obtained for 1000 5-FU-selected cells plated in LTC was 187 ± 16 (marrow at diagnosis), 182 ± 17 (blood at diagnosis), 187 ± 14 (CD34 + cells) and 172 ± 27 (marrow under IFN treatment). There was no significant difference between the colony yield according to the origin of cells. The number of secondary colonies was moderately but significantly higher when 5-FU-selected cells where obtained from normal marrow (232 ± 31 for MNC, 222 ± 31 for CD34 + cells, P Ͻ 0.01 by Student's t-test).
FISH and PCR studies (Table 3)
FISH studies performed before selection by 5-FU showed that 65-87% of MNC were scored positive for BCR/ABL rearrangement (mean 79%) when marrow or blood cells were studied at diagnosis. The percentage of positive marrow MNC was lower (28-71%, mean 55%) when the cells were harvested from patients receiving IFN␣. Controls on normal marrow MNC showed 1-4.5% cells (mean 2.1%) scored positive for BCR/ABL rearrangement. Immediately after 5-FU selection FISH studies could not be reliably performed because of the very high background level generated by dead cells. The results of selection were therefore assessed after LTC, on pooled adherent and non-adherent cells, or on individual secondary colonies. 5-FU-selected cells were able to generate secondary colonies which were BCR/ABL-negative in all 17 cases studied. Five-week LTC cells exhibited a percentage of positive cells comparable to that of normal marrow controls. By contrast, primary colonies generated from marrow of five CML patients (without prior selection or LTC) were all positive. Controls performed in five cases on secondary colonies obtained after 5-week LTC, but without prior 5-FU selection remained BCR/ABL-positive, although in two cases a significant number of normal colonies could be recovered (9/20 and 7/14 respectively).
RT-PCR confirmed that cells harvested after 5-week LTC, or cells from pooled secondary colonies were BCR/ABL negative in all cases. In some instances, cells harvested immediately after 5-FU selection were examined. RT-PCR was always negative. Representative results of RT-PCR performed on colonies grown at diagnosis or after 5-FU selection and 5-week LTC are presented in Figure 3 .
NOD/SCID studies
Experiments were performed with cells selected from peripheral blood of two patients at diagnosis (patients 6 and 8). In Number of secondary colonies obtained after 5-week long term culture, for 100 5-FU-selected cells initially seeded, according to cell origin. The frequency of human CAFC was assessed in the marrow 10 weeks after transplantation. All wells seeded with cells from CD34
+ transplanted mice were positive. The frequency of CAFC (for 100 seeded cells) was between 0.56 and 0.82 for 5-FU-transplanted mice.
Discussion
In this paper, we used the technique described by Berardi et al 27 to select hematopoietic progenitors from blood or marrow of patients with CML. This simple method allows the elimination of more mature progenitors while sparing very primitive cells lacking IL-3 receptor. The selected cells exhibit the ability to initiate long-term cultures and to differentiate into 30 showed that culture of mobilized PB stem cells in the presence of 5-FU, IL-3 and SCF also allowed isolation of primitive hematopoietic cells which were able to engraft NOD/SCID mice. The results presented here are consistent with those of Berardi and Bertolini, and show that hematopoietic progenitor with LTC-initiating cells and NOD/SCIDmouse repopulating potential can be isolated from blood and marrow of patients with CML at diagnosis but also from marrow of patients receiving IFN␣ therapy. The proportion of 5-FU-resistant cells was higher in normal marrow or in IFN␣-treated marrow than in CML marrow or peripheral blood. Presumably because of the excess of cycling progenitors in CML at diagnosis. The frequency of cobblestone areas generated by these cells (33-46% positive wells for one cell plated) did not significantly differ according to the cell origin (CML marrow or blood, or normal marrow), and was also similar to that reported by Berardi 27 (63-71% positive wells/cell). The major finding in this paper is the consistent absence of BCR/ABL rearrangement in cells selected by 5-FU or their progeny. Cells recovered immediately after a 7-day culture in the presence of 5-FU were negative for BCR/ABL rearrangement as assessed by RT-PCR in all samples studied, including those from patients who had been treated for several months and were poor responders to IFN␣ therapy. The existence of PH-positive progenitors with a PCR-negative BCR/ABL rearrangement has been described, 31, 32 probably because the BCR/ABL gene is not transcripted in quiescent primitive cells.
As FISH studies could not be reliably performed immediately after 5-FU selection because of a very high background fluorescence, we therefore assessed the presence of BCR/ABL rearrangement by FISH as well as RT-PCR on cells maintained in LTC for 5 weeks, or on secondary colonies generated after 5-week LTC. RT-PCR as well as FISH are powerful tools to detect leukemic colonies in CML, although the analysis by RT-PCR of individual colonies may generate false negative results. 33, 34 The data obtained here by both techniques show that 5-FU selected cells were able to generate LTC and secondary colonies which were BCR/ABL negative in all cases. By contrast, control cultures with unselected cells remained positive by both techniques. Interestingly, FISH studies performed after LTC of unselected cells showed in two cases a decrease in the proportion of positive colonies, but not a complete purging of the leukemic clone. Finally, blood cells of NOD/SCID mouse tested 10 weeks after transplantation were also negative by the RT-PCR method.
A variety of approaches have been tested to eliminate Ph cells from marrow or blood of CML patients, or to select normal stem cells in the purpose of autologous transplantation. Ex vivo treatment of CML marrow with cyclophosphamide derivatives, 5-FU alone or IFN gamma do not result in complete elimination of the Ph cells in a majority of patients, even at the level of committed progenitors. [11] [12] [13] As a consequence of the initial observations by Coulombel, 10 LTC have also been proposed to purge Ph cells from bone marrow. However, this method is practically difficult in the clinical setting and a safe and efficient selection of normal cells feasible in only one half of patients. 15 More recently, a selection of non-malignant cells on the basis of their immunophenotype has been proposed. 22 Marrow CD34 + DR − cells collected in early chronic phase were BCR/ABL and Ph negative in more than 80% of patients whereas the same cell fraction was normal in less than 40% of patients examined in advanced phase. The number of CD34 + DR − cells from patients in early chronic phase was similar to that observed in normal marrow. Furthermore, a large-scale selection of CD34 + DR − cells based on a first step of CD34 + enrichment and on a second step of high-speed sorting was proposed. Our results show that 5-FU-selected cells exhibit a CD34
+ DR − (as well as CD38 − ) phenotype. In all cases presented here, these cells and their progeny were BCR/ABL negative, even when collected from treated patients. This may indicate a better efficacy of our purging technique with a complete absence of contamination by residual leukemic cells. An alternative explanation is that we examined a more favorable patient population, as no patient in our series was in long-lasting chronic phase or in accelerated phase. Furthermore, some patients were already in cytogenetic response (major in one case). The study of samples from patients in more advanced phase should be performed to assess the persistence of normal stem cells at this stage of the disease and to compare the respective efficacy of immunological and culture purging methods.
In conclusion, our study indicates that BCR/ABL-negative primitive cells can be selected by a 7-day culture in the presence of 5-FU, IL-3 and SCF, at least at diagnosis or in early chronic phase. This method may be easier and does not necessitate sophisticated sorting facilities when compared to immunoselection. However the very low number of cells recovered and the fact that in vitro treatments with chemotherapeutic agents are associated with delayed post-transplant recovery might hamper the use of our method in clinical transplant. Ex vivo expansion after selection using combinations of cytokines including flt3-ligand might improve the number of transplantable cells with self-renewal properties as well as the purging procedure. 35 
